Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinberger, J.
Right arrow Articles by Cohen, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinberger, J.
Right arrow Articles by Cohen, G.

Stroke, Vol 16, 864-870, Copyright © 1985 by American Heart Association


ARTICLES

Nerve terminal damage in cerebral ischemia: protective effect of alpha- methyl-para-tyrosine

J Weinberger, J Nieves-Rosa and G Cohen

Mongolian gerbils were treated with alpha-methyl-para-tyrosine methyl ester (AMPT, a tyrosine hydroxylase inhibitor), in order to decrease brain levels of catecholamines. Six hours later, unilateral ischemic stroke was induced by ligation of the left common carotid artery. The delayed degeneration of nerve terminals was studied sixteen hours later by measuring the high-affinity uptake of radiolabeled transmitters by isolated synaptosomes. Dopamine, serotonin and glutamate terminals were studied. AMPT-treated gerbils were compared to untreated (no AMPT) animals; 220 gerbils were studied. AMPT pretreatment (100, 250 and 400 mg/kg) produced a dose-dependent protection of all three types of nerve terminals. In the absence of AMPT pretreatment, the uptake of radiolabeled transmitters by the ischemic hemisphere, expressed as a percentage of that seen in the contralateral (unaffected) side of the brain, was as follows (mean +/- SEM): 27.3 +/- 5.2% for dopamine terminals, 49.5 +/- 6.2% for serotonin terminals, and 42.7 +/- 5.3% for glutamate terminals. Protection was essentially complete at a dose of 400 mg AMPT per kg. The number of animals with significant damage to nerve terminals was reduced from 38.5% in untreated animals to 11.1% in animals treated with AMPT 400 mg/kg. Although the nerve terminals were protected, gerbils still showed the behavioral signs of unilateral stroke due to the permanent occlusion of the left carotid. These results indicate that endogenous dopamine may play a significant role in ischemic damage to nerve terminals in the cerebrum.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
L. Y. Moy, S.-P. Wang, and P. K. Sonsalla
Mitochondrial Stress-Induced Dopamine Efflux and Neuronal Damage by Malonate Involves the Dopamine Transporter
J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 747 - 756.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T.-Y. Chen, T. Goyagi, T. J.K. Toung, J. R. Kirsch, P. D. Hurn, R. C. Koehler, and A. Bhardwaj
Prolonged Opportunity for Ischemic Neuroprotection with Selective {kappa}-Opioid Receptor Agonist in Rats
Stroke, May 1, 2004; 35(5): 1180 - 1185.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. Goyagi, A. Bhardwaj, R. C. Koehler, R. J. Traystman, P. D. Hurn, and J. R. Kirsch
Potent {sigma}1-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl) Piperidine Provides Ischemic Neuroprotection Without Altering Dopamine Accumulation In Vivo in Rats
Anesth. Analg., February 1, 2003; 96(2): 532 - 538.
[Abstract] [Full Text] [PDF]